Importantly, the FDA labels for semaglutide products note that these medications have not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and are not recommended for use in these populations
Of the 15 subclasses in the serum lipidome, phosphatidylcholines (PC
Conclusion Bruising after GLP-1 injections can often be avoided with a few simple steps
Age-related changes in the brain antioxidant status: modulation by dietary supplementation of Decalepis hamiltonii and physical exercise
One medication that has been gaining significant attention in weight management is semaglutide, a GLP-1 receptor agonist known for its dual benefits in regulating appetite
This is particularly relevant for advanced stage IV cancers and challenging-to-treat brain tumors such as glioblastoma multiforme, which are difficult to surgically remove (Zuccoli et al